Diabetes mellitus aggravates ranolazine-induced ECG changes in rats-Reference-Cited by-同舟云学术

Diabetes mellitus aggravates ranolazine-induced ECG changes in rats

Published:2021-06-21 Issue: Volume: Page:
ISSN:1383-875X
Container-title:Journal of Interventional Cardiac Electrophysiology
language:en
Short-container-title:J Interv Card Electrophysiol

Author:

Mashayekhi-Sardoo Habibeh^ORCID,Mohammadpour Amir Hooshang^ORCID,Mehri Soghra^ORCID,Kamali Hossein^ORCID,Sahebkar Amirhossein^ORCID,Imenshahidi Mohsen^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Link

https://link.springer.com/content/pdf/10.1007/s10840-021-01016-9.pdf

Reference53 articles.

1. Zheng Y, Ley SH, Hu FB. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol. 2018;14(2):88–98.

2. Ahmad FS, et al. Hypertension, obesity, diabetes, and heart failure-free survival: the cardiovascular disease lifetime risk pooling project. JACC Heart Fail. 2016;4(12):911–9.

3. Kenny HC, Abel ED. Heart failure in type 2 diabetes mellitus. Circ Res. 2019;124(1):121–41.

4. Diabetes and Coronary Heart Disease. N Engl J Med. 1998;339(23):1714–6.

5. Shah AD, et al. Type 2 diabetes and incidence of cardiovascular diseases: a cohort study in 1· 9 million people. Lancet Diabetes Endocrinol. 2015;3(2):105–13.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhancement of Physicochemical and Pharmacokinetic Characteristics of Ranolazine drug substance using Cocrystalization Technique;Research Journal of Pharmacy and Technology;2024-01-19

2. Comparison of pharmacokinetic parameters of ranolazine between diabetic and non-diabetic rats;IRAN J BASIC MED SCI;2022